Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients.
Xingxin ZhangChenjian GuQian WeiYirong CaoWeimin SheHong ShiYou-Hua XieJinsheng GuoPublished in: Journal of hepatocellular carcinoma (2023)
Pre-S1 is a biomarker that indicates the presence and replication of HBV. Pre-S1 sustained negativity attributed to pre-S1 mutations in CHB patients may be associated with a higher risk of HCC, which has clinical significance and warrant further investigations.